Sessions

Session Date
MyeloMATCH: An NCTN precision medicine initiative for the evaluation of novel therapies in patients with newly diagnosed AML and MDS 03/11/2024 - 4:00pm to 5:00pm EDT
A Journey of Multi-Disciplinary Efforts 03/18/2024 - 4:00pm to 5:00pm EDT
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 03/25/2024 - 4:00pm to 5:00pm EDT
VEXAS Syndrome 04/01/2024 - 4:00pm to 5:00pm EDT
The Role of Autologous Transplantation in the Management of Mantle Cell Lymphoma 04/08/2024 - 4:00pm to 5:00pm EDT
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 04/15/2024 - 4:00pm to 5:00pm EDT
Therapeutic Targeting of STAT3 in Myeloid Malignancies 04/22/2024 - 4:00pm to 5:00pm EDT
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 04/29/2024 - 4:00pm to 5:00pm EDT
Point-of-care Manufacturing of Cell therapies: Opportunities and Challenges 05/06/2024 - 4:00pm to 5:00pm EDT
MRD+ After Frontline Fixed Duration Venetoclax and Obinutuzumab: What Now? 05/13/2024 - 4:00pm to 5:00pm EDT

Pages